Replies to post #668 on Galectin Therapeutics Inc. (GALT)

[thefamilyman]

Your autocorrect is changing efficacy to efficiency. :-) Other than that I agree with your comments.


DirectionalDriller said...

ICPT shows us that the market considers NASH treatment to be worth 8 to 9 billion market cap currently. That would put GALT's pps 400 to 500 range if successful in gaining efficiency.